ANI intros generic Compazine

ANI is offering prochlorperazine maleate tablets, the generic of Compazine.

The medication, which is used to treat the symptoms of psychosis and severe nausea or vomiting, was developed in technical collaboration with Biophore.

[Read more: ANI appoints new legal executive]

“We are pleased to bring prochlorperazine, another limited competition product to the market and provide customers and patients access to high quality generics,” said Nikhil Lalwani, president and CEO of ANI.

"In keeping with our mission of providing affordable, high quality options for patients, we are pleased to partner with ANI on the launch of this limited-competition product,” said Jagadeesh Rangisetty, CEO of Biophore.

[Read more: ANI intros Cortrophin Gel]

Prochlorperazine maleate tablets have a market value of roughly $30 million, according to IQVIA.